Arich Enterprise Co., Ltd. (TPEX:4173)
Taiwan
· Delayed Price · Currency is TWD 22.55
+0.70 (3.20%)
May 2, 2025, 1:30 PM CST
Arich Enterprise Revenue
In the year 2024, Arich Enterprise had annual revenue of 1.30B TWD with 13.83% growth. Arich Enterprise had revenue of 334.31M in the quarter ending December 31, 2024, with 18.37% growth.
Revenue
1.30B
Revenue Growth
+13.83%
P/S Ratio
1.26
Revenue / Employee
6.55M
Employees
198
Market Cap
1.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.30B | 157.69M | 13.83% |
| Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
| Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
| Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
| Dec 31, 2020 | 1.25B | 139.25M | 12.52% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Polaris Group | 107.00M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |